Fund Holdings — Rosalind Advisors, Inc.

Total Portfolio Value:
$206.65M
Total Bought:
$44.46M
Total Sold:
$38.57M
Net Transaction:
+$5.89M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Delcath Systems, Inc.(DCTH)2,900,3893,300,389+400,000$29.00M$33.00M15.97%+$4.00M
Fennec Pharmaceuticals Inc.(FENC)1,782,8442,045,644+262,800$10.86M$16.98M8.22%+$6.12M
Cytokinetics, Incorporated(CYTK)0400,000+400,000$0$13.22M6.40%+$13.22M
Ocular Therapeutix, Inc.(OCUL)1,218,7001,218,7000$8.93M$11.31M5.47%+$2.38M
IDEAYA Biosciences, Inc.(IDYA)700,000511,132-188,868$11.47M$10.74M5.20%-$722.0K
Xeris Biopharma Holdings Inc2,495,9862,155,594-340,392$13.70M$10.07M4.87%-$3.64M
Viridian Therapeutics, Inc.(VRDN)595,000700,000+105,000$8.02M$9.79M4.74%+$1.77M
Verona Pharma PlcADS100,000100,0000$6.35M$9.46M4.58%+$3.11M
Verastem, Inc.(VSTM)2,644,5172,043,563-600,954$15.95M$8.48M4.10%-$7.47M
Replimune Group, Inc.(REPL)850,000900,000+50,000$8.29M$8.36M4.05%+$73.5K
MediWound Ltd.SHS NEW(MDWD)506,893407,061-99,832$7.87M$7.88M3.82%+$17.8K
Myomo, Inc.(MYO)2,703,6613,595,788+892,127$13.00M$7.77M3.76%-$5.24M
Rezolute, Inc.(RZLT)01,741,211+1,741,211$0$7.77M3.76%+$7.77M
UroGen Pharma Ltd.(URGN)950,000542,366-407,634$10.51M$7.43M3.60%-$3.08M
Cybin D/B/A Helus Pharma(HELP)810,918810,9180$5.14M$6.80M3.29%+$1.66M
Savara Inc.(SVRA)2,654,9442,654,9440$7.35M$6.05M2.93%-$1.30M
InspireMD, Inc.(NSPR)2,274,9902,289,099+14,109$6.12M$5.20M2.51%-$923.5K
CG Oncology, Inc.(CGON)0192,974+192,974$0$5.02M2.43%+$5.02M
Profound Medical Corp.(PROF)692,185692,1850$4.03M$4.08M1.98%+$55.4K
Pharvaris N V
COM
223,627223,6270$3.51M$3.94M1.90%+$424.9K
PolyPid Ltd.(PYPD)1,018,021975,462-42,559$2.76M$3.44M1.67%+$684.5K
Mind Medicine Mindmed Inc420,000420,0000$2.46M$2.73M1.32%+$268.8K
Kalvista Pharmaceuticals Inc303,864157,725-146,139$3.51M$1.78M0.86%-$1.72M
Trevi Therapeutics, Inc.(TRVI)612,901300,000-312,901$3.86M$1.64M0.79%-$2.21M
COMPASS Pathways plcADS(CMPS)823,286482,651-340,635$2.35M$1.35M0.65%-$1.00M
Talphera, Inc.(TLPH)2,003,9392,003,9390$992.0K$922.2K0.45%-$69.7K
Biofrontera Inc.(BFRI)644,393976,448+332,055$515.5K$694.7K0.34%+$179.2K
Kura Oncology, Inc.(KURA)100,000100,0000$660.0K$577.0K0.28%-$83.0K
Ovid Therapeutics Inc.(OVID)0500,000+500,000$0$164.9K0.08%+$164.9K
Abeona Therapeutics Inc.(ABEO)1,805,8170-1,805,817$8.60M$0—-$8.60M
Alpha Cognition Inc. Common Stock(ACOG)104,8360-104,836$530.5K$0—-$530.5K
Cogent Biosciences, Inc.(COGT)248,2850-248,285$1.49M$0—-$1.49M
Kiora Pharmaceuticals, Inc.(KPRX)250,0590-250,059$752.7K$0—-$752.7K
Nuvation Bio Inc.CL A(NUVB)2,451,5000-2,451,500$4.31M$0—-$4.31M
Optinose Inc256,1900-256,190$2.35M$0—-$2.35M
Page 1 of 1
Rosalind Advisors, Inc. — 13F Holdings — Q2 2025 | TickerTrail